1. Home
  2. PYN vs ANEB Comparison

PYN vs ANEB Comparison

Compare PYN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYN
  • ANEB
  • Stock Information
  • Founded
  • PYN 2002
  • ANEB 2020
  • Country
  • PYN United States
  • ANEB United States
  • Employees
  • PYN N/A
  • ANEB N/A
  • Industry
  • PYN Investment Managers
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PYN Finance
  • ANEB Health Care
  • Exchange
  • PYN Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • PYN 34.5M
  • ANEB 36.7M
  • IPO Year
  • PYN N/A
  • ANEB 2021
  • Fundamental
  • Price
  • PYN $5.82
  • ANEB $1.47
  • Analyst Decision
  • PYN
  • ANEB Buy
  • Analyst Count
  • PYN 0
  • ANEB 1
  • Target Price
  • PYN N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • PYN 19.9K
  • ANEB 13.1K
  • Earning Date
  • PYN 01-01-0001
  • ANEB 02-21-2025
  • Dividend Yield
  • PYN 5.07%
  • ANEB N/A
  • EPS Growth
  • PYN N/A
  • ANEB N/A
  • EPS
  • PYN N/A
  • ANEB N/A
  • Revenue
  • PYN N/A
  • ANEB N/A
  • Revenue This Year
  • PYN N/A
  • ANEB N/A
  • Revenue Next Year
  • PYN N/A
  • ANEB N/A
  • P/E Ratio
  • PYN N/A
  • ANEB N/A
  • Revenue Growth
  • PYN N/A
  • ANEB N/A
  • 52 Week Low
  • PYN $4.84
  • ANEB $0.80
  • 52 Week High
  • PYN $6.60
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • PYN 60.65
  • ANEB 44.55
  • Support Level
  • PYN $5.68
  • ANEB $1.45
  • Resistance Level
  • PYN $5.77
  • ANEB $1.72
  • Average True Range (ATR)
  • PYN 0.04
  • ANEB 0.14
  • MACD
  • PYN 0.02
  • ANEB -0.01
  • Stochastic Oscillator
  • PYN 89.47
  • ANEB 22.28

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: